Treatment of type II hyperlipoproteinaemia with cholestyramine.
D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000037:antagonists & inhibitors; D001796:Blood Protein Disorders / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D000925:Anticoagulants; D008074:Lipoproteins; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol